Skip to main content
Terug
Watch Compare

IR-Med, Inc.

Datakwaliteit: 83%
IRME
OTC Manufacturing Measuring & Analyzing Instruments
€ 0,01
€ 0,00 (0,00%)
Marktkapitalisatie: 768.670,0
Prijs
€ 0,01
Marktkapitalisatie
768.670,0
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -839.000,0

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio0,12
Interest Coverage-488,00

Waardering

PE (TTM)
-0,33
Boven sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -0,3 -1,5
P/B — 1,6
ROE % — -53,6
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q32024 -€ 0,01 -€ 0,01 0,0%
Q22024 -€ 0,01 -€ 0,01 0,0%
Q12024 -€ 0,02 -€ 0,01 +50,0%
Q42023 -€ 0,02 -€ 0,02 0,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -2,35 M
ROE N/A ROA -1571,91%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -839.000,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,12
Interest Coverage -488,00 Asset Turnover N/A
Working Capital -684.000 Tangible Book Value -625.000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,33 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -109,15%
Market Cap 768.670,0 Enterprise Value 705.670,0
Per Share
EPS (Diluted TTM) -0,04 Revenue / Share N/A
FCF / Share -0,01 OCF / Share -0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 35,70%
SBC-Adj. FCF -1,38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue — — — —
Net Income -1,90 M -4,91 M -4,73 M -3,72 M
EPS (Diluted) -0,03 -0,07 — —
Gross Profit — — — —
Operating Income -1,94 M -4,91 M -4,76 M -3,68 M
EBITDA — — — —
R&D Expenses 710.000,0 2,06 M 1,89 M 1,42 M
SG&A Expenses — — — —
D&A — — — —
Interest Expense -3.000,0 20.000,0 — —
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 251.000,0 999.000,0 3,29 M 2,94 M
Total Liabilities 545.000,0 634.000,0 702.000,0 572.000,0
Shareholders' Equity -294.000,0 365.000,0 2,59 M 2,37 M
Total Debt — — — —
Cash & Equivalents 129.000,0 767.000,0 3,00 M 2,82 M
Current Assets 205.000,0 848.000,0 3,06 M 2,88 M
Current Liabilities 545.000,0 473.000,0 662.000,0 —